Extend Biosciences is awarded a Phase I grant from NIAID
Extend Biosciences was awarded a Phase I SBIR grant from the National Institute of Allergy and Infectious Disease to work on a program for acute radiation syndrome.
Extend Biosciences was awarded a Phase I SBIR grant from the National Institute of Allergy and Infectious Disease to work on a program for acute radiation syndrome.